Based on its recent research on the omega-3 market, Frost & Sullivan presents Epax AS with the 2012 European Frost & Sullivan Award for Product Differentiation Excellence. The company's range of omega-3 industry ingredient products has carved a niche in a crowded market by developing innovative solutions that address specific disorders, unlike competing products that support the general wellbeing of individuals.
Omega-3 has earned the name of a beneficial ingredient with proven benefits to address conditions pertaining to heart health, pre and post natal health, cognitive health, eye health, and joint health. The market has many participants, all aiming to provide multiple benefits to end users.
"Product differentiation is one of the prime factors that define success in the omega-3 market," said Frost & Sullivan Research Analyst Ashwin Raj Ravinder. "Epax is one of the earliest patrons that have brought in the concept of condition-specific formulas enrooted to target solitary needs of the consumer."
The Epax product range is primarily derived from fish oil with an optimum eicosapentaenoic acid to docosahexaenoic acid (EPA:DHA) ratio, thereby offering a cost-effective solution compared to omega-3 derived from algal and vegetable sources. The company offers three different omega-3 oil formats, encompassing many possible combinations of EPA and DHA, where each combination is positioned to combat specific ailments. Multitudinous clinical studies and European Food Safety Authority (EFSA)-approved health claims further strengthen the ability to effectively market Epax AS' omega-3 products.
The company leads from front in assuring quality of its products. Strategic alliances with raw material suppliers and the purity of the products form the crux of Epax AS' business. The entire supply chain – from the fisheries to the Epax state-of-the art manufacturing technology that not only prevents the accumulation of environmental pollutants but also enhances the shelf life of the products – lays stress on maintaining the high quality of the products. Previously, in 2008 Epax received a Frost &Sullivan Best Practice award for Excellence in Product Quality Award in the European Omega-3 ingredient market. Purity beyond expectations concept, Epax's high quality focus has enabled and been key to the company to take the step into high-quality condition –specific ingredients
Moreover, Epax has always focused on the welfare of the environment, earning the name of an environment friendly company, a difficult feat to achieve in the current market place. The purity, safety and robust science associated with Epax AS' product portfolio have given the brand the holistic image of a high performance ingredient. Some of the accolades include EHS (environmental health and safety) engineering, ISO 14001 certification, Eco heating, zero waste, and Registration, Evaluation, Authorization of Chemical Substances (REACH)-compliance.
By solely focusing on its core business of omega-3 concentrates, Epax precludes the risk of cross contamination. Even though the Epax omega-3 product range can be incorporated into functional foods and beverages, Epax's strong know-how and expertise in the field have made it the ardent choice for many soft gel and dietary supplement manufacturers. The high concentrate products have made it compatible in every possible supplement without any hindrance to the processes involved.
"Apart from offering a product that possesses all the goodness of omega-3, Epax has truly emerged as a global company having footprints across the world, thereby creating a global image to its products," added Ravinder. "Epax's expeditious team of experts helps customers throughout the globe, to formulate, market and sell the high concentrate omega-3 products and also extends its services by offering regulatory support for international customers."
Overall, its positive brand image among industry customers/in the omega-3 industry, unique mode of action and adequate science have helped Epax AS to attain a strong position in the fast developing omega-3 ingredients industry. In recognition, Frost & Sullivan is pleased to present the company with the 2012 European Product Differentiation Excellence Award.
Each year, Frost & Sullivan presents this award to the company that has developed a product concept with unique features/functionality as well as high quality for consumers with complex needs. The award lauds the degree of the products customization and the fit for evolving market trends, which ultimately results in a strong brand perception of the product as being unique.
Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
Epax is a 50/50 joint venture between Aker BioMarine ASA and Lindsay Goldberg LLC. Epax is the world leader in marine-derived omega-3 fatty acid concentrates. The company offers a wide range of high quality marine omega-3 concentrates in the nutraceutical business-to-business segment, as well as pharmaceutical intermediates and active pharmaceutical ingredients (API). The Epax group is headquartered in Oslo, Norway, with cGMP manufacturing facilities in Ålesund, Norway and Seal Sands, UK.
About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Contact Us: Start the discussion | Join Us: Join our community | Subscribe: Newsletter on "the next big thing" | Register: Gain access to visionary innovation.